Nadolol in essential tremor.
Nadolol, 120 and 240 mg daily, reduced essential tremor in a placebo-controlled double-blind study. The effect was observed in patients who had previously responded to propranolol but not in those who had not benefited from propranolol therapy.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol; D010919:Placebos; D011412:Propanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014202:Tremor / Q000188:drug therapy*
D010919:Placebos; D011412:Propanolamines; D009248:Nadolol; D011433:Propranolol